Conferences

Drug R&D 2025 will be held in Boston Marriott Newton, from 10 to 12 February 2025. This three-day program highlights pivotal platforms and technologies influencing early-stage drug pipelines, spanning from DNA-encoded libraries and phenotypic screening to AI algorithms and organoid models. Esteemed experts in target discovery and validation from various small and large biopharma entities converge to deliberate on how emerging therapeutic paradigms can surmount longstanding obstacles in drug development and yield refined, innovative drug candidates. Additional sessions delve into the integration of automation to enhance drug development processes and elevate laboratory productivity, exemplifying the competitive edge attainable in drug development through digitalization and robotics.

For more information, please click here:

https://d-rnd.com/

The ACSMEDI-EFMC Medicinal Chemistry Frontiers is co-organized by ACS MEDI (Division of Medicinal Chemistry of the American Chemical Society) and EFMC (European Federation for Medicinal chemistry and Chemical biology). The 2025 edition will be organized in Chicago, IL, United States.

The 2025 program will include the following:

• Three high-quality plenary lectures;
• Nine sessions on key topics in Medicinal Chemistry;
• About 18 oral communications selected from the submitted abstracts;
• An extensive social program to maximise your networking opportunities;
• A poster session and a commercial exhibition.

The ACSMEDI-EFMC Medicinal Chemistry Frontiers Meeting attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular, medicinal and synthetic chemists, together with scientists active in the fields of computer-assisted drug design, biology, DMPK, pharmacology, and early toxicology.

The 2025 edition is chaired by Prof. Terry W. Moore (University of Illinois, Chicago, IL, United States).

For more information, please visit here:

https://www.medchemfrontiers.org/